Furthermore, β.anti-NKG2A.IL-15 stimulated PBMCs killed 92% (± 3.62%) of Raji cells as compared to 28% (± 6.91%) for β.anti-NKG2A, emphasizing the requirement of IL-15 for an optimal cytotoxicity against resistant cancer cells. This evidence concerns the gene IL15 and cancer.